The Cochrane Library

Business Profile

Core Value Proposition

[The Cochrane Library] provides reliable, up-to-date health evidence and learning resources to empower decision-makers, patients and the public to make informed health decisions.

Target Customer

{"Scientists","Policymakers","Decision-makers","Healthcare professionals","Researchers","Patients and the public"}

Key Differentiator

Global, collaborative evidence ecosystem with language diversity and broad public involvement: translations into 20+ languages, a network spanning 100+ countries, high impact on policy (e.g., 75% of WHO guidelines cite at least one Cochrane review), and open access components including an evidence synthesis journal.

Implementation Timeline

Not specified in the content; value and updates are indicated as ongoing (evidence and translations exist now; updates referenced in news items from 2025).

Pain Points

1Need for trustworthy, reliable health evidence to inform decisions and policy
2Language barriers and access limitations to high-quality health evidence
3Demand for guidance and support in evidence production, authorship, and tailored evidence services

Key Features

1The Cochrane Library and Cochrane evidence—trusted, up-to-date health evidence and learning resources
2Translation of evidence into 20+ languages
3Global network spanning over 100 countries
4Free health evidence and learning resources for all
5Tools, data and custom services for users of health evidence (custom evidence service; guidance for writing Cochrane reviews; becoming a Cochrane author)

Target Customer Industries

Decision Makers

1Chief Executive Officer
2Peer Reviewer
3Cochrane Author

Client Results

175% of new World Health Organization guidelines in the past 5 years cite at least one Cochrane review
2Evidence translated into 20+ languages
3Global network spans over 100 countries
4Patients and the public help produce the evidence
5Free health evidence and learning resources available to all

Competitive Advantages

1High trust and impact in policy and decision-making (e.g., WHO guideline citations)
2Global reach with broad language accessibility
3Public involvement in evidence production
4Free access to health evidence and educational resources
5Availability of custom evidence services and authoring guidance
6Dedicated open-access journal (Cochrane Evidence Synthesis and Methods) for synthesis methodology

Key Benefits

1Reliable, up-to-date health evidence

2Supports informed decision-making for individuals and organizations

3Global reach and multilingual access

4Free health evidence and learning resources

5Opportunities for custom evidence services and guidance for authors

Case Studies & Success Stories

Our daughters, our future: Pakistan’s HPV vaccination campaign offers hope

Case #1

Pakistan introduced the HPV vaccine for girls, aiming for a 90% vaccination rate; Dr Muhammad Tayyab Qureshi of Cochrane Pakistan reflects on the campaign and the value of investing in girls’ futures.

RSV vaccines safe and effective, Cochrane review finds

Case #2

Cochrane review indicates vaccines for respiratory syncytial virus reduce infection risk in older adults and infants.

Additional Product Information

Product Description

A global source of health evidence produced by The Cochrane Collaboration, offering reliable, up-to-date health evidence and learning resources, translations into multiple languages, free resources, and options for custom evidence services.

Target Market

Researchers, policymakers, decision-makers, healthcare professionals, patients and the public across a global network

Unique Value Proposition

Trusted, globally collaborative health evidence ecosystem with multilingual translations, free resources, patient/public involvement, and access to custom evidence services and author guidance.

Technical Requirements

Not specified in the content

Pricing Model

Free access to health evidence and learning resources; additional services exist but pricing is not specified in the content

Companies Solving Similar Problems

Based on matching: problems solved, target roles, key features, industries

Arda Therapeutics

Arda Therapeutics provides therapies to eliminate pathogenic cells that drive chronic diseases, offering greater efficacy and faster discovery timelines.